Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Scientific Poster
June 19, 2016

Fit for Purpose Development and Validation of a Urea Biomarker Assay to Support Pre-Clinical Studies

Finding a suitable assay for measuring urea levels during human clinical trials
Authors: George Hristopoulos, Douglas Aguilar, Vivian Pettis, Benjamin Hopper, Patrick Smith, Karen Williams, Christina Axelson, Andrea Hall, Kathy Champion, and Paul Rhyne

Presented at the 2016 AAPS National Biotechnology Conference, this posted details the team’s efforts to develop and perform a fit for purpose validation of a biomarker assay to measure changes in urea levels in mouse plasma and broncho-alveolar fluid (BAL). Q2 Solutions has the breadth and depth of biomarker expertise, tools and capabilities to prepare and implement strategies to help drug developers effectively gain a competitive advantage – helping ensure your success in clinical trials, regulatory approvals and new product launches.   

Q2 Solutions is your partner of choice for any development program which requires identifying, designing and/or validating biomarkers, because we’re able to go a step further to help you understand how these biomarkers can help deliver actionable insights for better health™.
Best Practices for Integrating Biomarkers across the Drug Development Continuum

A roadmap for a successful biomarker strategy

Bioanalytical & ADME Laboratory Services

Accelerate and enhance your discovery, preclinical and clinical programs

Read More